摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

sodium N-(7-chloro-4-quinoyl)-anthranilate | 49713-71-5

中文名称
——
中文别名
——
英文名称
sodium N-(7-chloro-4-quinoyl)-anthranilate
英文别名
sodium salt of N-(7-chloro-4-quinolyl)-anthranilic acid;N-(7-chloro-4-quinolyl)-anthranilic acid sodium salt;sodium;2-[(7-chloroquinolin-4-yl)amino]benzoate
sodium N-(7-chloro-4-quinoyl)-anthranilate化学式
CAS
49713-71-5
化学式
C16H10ClN2O2*Na
mdl
——
分子量
320.71
InChiKey
LENZMLNHBQIMIB-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.0
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Analgesically or anti-inflammatory effective 4-quinolyl anthranilic acid
    申请人:Recordati S.A.
    公开号:US04507308A1
    公开(公告)日:1985-03-26
    The novel anthranilic acid derivatives having the structural formula (I): ##STR1## wherein n is 0, 1 or 2, one of R.sub.1 and R.sub.2 is chloro or trifluoromethyl and the other is hydrogen, and R is 2-oxo-3-oxolanyl or 2-oxo-3-oxazolidinyl, are effective analgesics and anti-inflammatories.
    该小说中的邻氨基苯甲酸衍生物具有结构式(I):其中n为0、1或2,R.sub.1和R.sub.2中的一个是氯或三氟甲基,另一个是氢,R为2-氧代-3-氧代戊二烯基或2-氧代-3-氧代氮杂环丙烷基,是有效的镇痛剂和抗炎药。
  • Therapeutically effective piperidyl
    申请人:Recordati, S. A., Chemical & Pharmaceutical Co.
    公开号:US04482561A1
    公开(公告)日:1984-11-13
    The N-substituted-4-(optionally substituted)-2-, 3- or 4-piperidyl N-(7- or 8-substituted-4-quinolyl)-anthraniloyloxyalkanoates having the structural formula (I): ##STR1## in which R is a straight or branched chain alkyl radical having from 1 to 4 carbon atoms; an alkenyl or alkynyl radical having from 2 to 6 carbon atoms; a benzyl, phenethyl, 4-nitrophenethyl or 4-aminophenethyl radical; or a phenacyl, benzoylethyl, .beta.-hydroxyphenethyl or .alpha.-hydroxyphenylpropyl radical, optionally substituted on the phenyl ring by one or more halogen atom, trifluoromethyl, nitro or amino substituents, or an alkyl substituent having from 1 to 4 carbon atoms or an alkoxy substituent having from 1 to 4 carbon atoms; R.sub.1 is a hydrogen atom or a phenyl radical; each of R.sub.2 and R.sub.3 is independently a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms; one of R.sub.4 and R.sub.5 is a chlorine atom or a trifluoromethyl radical and the other of R.sub.4 and R.sub.5 is a hydrogen atom; and the pharmaceutically acceptable salts of such esters; are effective analgesics, anti-inflammatories and antidepressants; are also strong inhibitors of platelet aggregation, and thus too are useful in the treatment of cerebral thrombosis, cerebral and cardiac infarction, and arteriosclerotic disorders.
    具有结构式(I)的N-取代-4-(可选择取代)-2、3或4-哌啶基N-(7-或8-取代-4-喹啉基)-蒽酰氧烷酸酯是有效的镇痛剂、抗炎药和抗抑郁药;它们还是强力的血小板聚集抑制剂,因此在治疗脑血栓形成、脑和心肌梗死以及动脉硬化性疾病方面也很有用。其中R是具有1到4个碳原子的直链或支链烷基基团;具有2到6个碳原子的烯基或炔基基团;苄基、苯乙基、4-硝基苯乙基或4-氨基苯乙基基团;或苯乙酰基、苯乙酰乙基、β-羟基苯乙基或α-羟基苯丙基基团,可选择在苯环上通过一个或多个卤素原子、三氟甲基、硝基或氨基取代基,或具有1到4个碳原子的烷基取代基或具有1到4个碳原子的烷氧基取代基;R.sub.1是氢原子或苯基基团;R.sub.2和R.sub.3中的每一个独立地是具有1到4个碳原子的烷基基团;R.sub.4和R.sub.5中的一个是氯原子或三氟甲基基团,另一个是氢原子;以及这些酯的药用盐。
  • Anthranilic acid esters
    申请人:RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY
    公开号:EP0076600A1
    公开(公告)日:1983-04-13
    Anthranilic acid esters I have analgesic and anti-inflammatory properties. They are prepared by condensing a salt (preferably Na) of an N-(7- or 8-substituted-4-quinolyl)-anthranilic acid with a haloderiva- tive Halo-(CH2)n-R. The condensation conditions are suitably equimolar proportion, 30 to 150°C, DMF as solvent. Pharmaceutical preparations are also disclosed.
    蒽酸酯 I 具有镇痛和消炎作用,其制备方法是将 N-(7-或 8-取代的-4-喹啉基)-蒽酸的盐(最好是 Na)与卤代-(CH2)n-R 缩合。 缩合条件为适当的等摩尔比例、30 至 150°C、DMF 作为溶剂。 还公开了药物制剂。
  • Soeder, Alfons; Perrey, Klaus, Polish Journal of Chemistry, 1980, vol. 54, # 6, p. 1305 - 1311
    作者:Soeder, Alfons、Perrey, Klaus
    DOI:——
    日期:——
  • SOEDER A.; PERREY K., POL. J. CHEM., 1980, 54, NO 6, 1305-1311
    作者:SOEDER A.、 PERREY K.
    DOI:——
    日期:——
查看更多